The Staurosporine-Performance

We now refer to AT deficiency (rather than ATIII deficiency), and deficiency of AT is the most clinically severe deficiency of a natural anticoagulant. Its prevalence in the healthy population has been reported to be between 1 in 600 and 1 in 5000 (Harper et?al., 1991a; Tait et?al., 1994). http://www.selleckchem.com/products/epz-5676.html Antithrombin is synthesized by the liver and circulates in plasma at a concentration of around 125?mg/l (2.3?��m) with a half-life in the region of 65?h. After removal of a 32-amino acid signal peptide, the 432-amino acid mature glycoprotein has a molecular weight of approximately 58?200 daltons and has four glycosylation sites at Asn128, Asn167, Asn187 and Asn224 which have variable sialic acid content (note that amino acids in AT are numbered 1�C464). Around 5�C10% of plasma AT is not glycosylated at Asn167 and is termed AT beta, and despite being a minor http://www.selleck.cn/products/Staurosporine.html proportion of AT, it may be physiologically important because it has a higher affinity for heparin than the major form, which is known as AT alpha. The variable glycosylation can be demonstrated using electrophoretic techniques, such as isoelectric focussing, where multiple isoforms of AT can be visualized in normal plasma (Bayston et?al., 1999; Kottke-Marchant & Duncan, 2002). When AT binds to specific sulphate groups on the pentasaccharide structure of heparin, the reactive site loop containing the P1�CP1�� reactive site (Arg 425�CSer 426) is released and AT activity is increased by more than a 1000-fold. Thrombin and AT form a stable inactive 1?:?1 stoichiometric complex that is removed by cells of the reticuloendothelial system. Early investigations of AT activity studied inhibition of thrombin, but it is now known that AT inhibits factors Xa, IXa, http://www.selleckchem.com/products/ly2109761.html XIa, XIIa and VIIa when in complex with tissue factor. In contrast to inhibition of other clotting factors, inhibition of thrombin by AT requires thrombin to bind to heparin and to be in close proximity to the heparin-bound AT, and this is only possible with higher molecular weight heparin comprised of at least eighteen saccharide units. Therapeutic low molecular weight heparin has a high proportion of heparin molecules with